Table 2 Serum SAA in non-cancer (healthy), benign disease and USPC patients

From: Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer

Subject group

N

Median (95% CI) a

Range a

Healthy

51

6.0 (4.0–8.9)

1.6–169.2

Benign disease

42

6.0 (4.2–8.1)

1.1–189.9

USPC

30

15.6 (9.2–56.2)

2.1–4000

Pairwise comparison

 

Area under ROC curve b

P -value c

Healthy vs benign

 

0.506

0.917

Healthy vs USPC

 

0.732

0.0005

Benign vs USPC

 

0.739

0.0006

  1. aMedians, 95% confidence intervals, and ranges of serum SAA are in μg ml−1.
  2. bValues near 0.50 denote highly overlapping distributions; values near 1.00 denote highly separated distributions.
  3. cP-values are from the two-sided Wilcoxon–Mann–Whitney test of the indicated comparison.
Back to article page